These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25331069)

  • 21. Facts and artefacts of coagulation assays for factor Xa inhibitors.
    Haas S
    Thromb Haemost; 2010 Apr; 103(4):686-8. PubMed ID: 20174751
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.
    Iba T; Levy JH; Warkentin TE; Thachil J; van der Poll T; Levi M;
    J Thromb Haemost; 2019 Nov; 17(11):1989-1994. PubMed ID: 31410983
    [No Abstract]   [Full Text] [Related]  

  • 23. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.
    Patel IJ; Davidson JC; Nikolic B; Salazar GM; Schwartzberg MS; Walker TG; Saad WA;
    J Vasc Interv Radiol; 2012 Jun; 23(6):727-36. PubMed ID: 22513394
    [No Abstract]   [Full Text] [Related]  

  • 24. Coagulopathy and transfusion therapy in pediatric liver transplantation.
    Nacoti M; Corbella D; Fazzi F; Rapido F; Bonanomi E
    World J Gastroenterol; 2016 Feb; 22(6):2005-23. PubMed ID: 26877606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants.
    Barnes GD; Nallamothu BK; Sales AE; Froehlich JB
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):182-5. PubMed ID: 26933047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the implementation of a quality improvement initiative: weekend gastrojejunostomy tube maintenance service in a tertiary pediatric center.
    Jaskolka D; Brown N; Cohen E; Mounstephen W; Connolly B
    Can Assoc Radiol J; 2013 Aug; 64(3):229-35. PubMed ID: 22503326
    [No Abstract]   [Full Text] [Related]  

  • 27. Developmental hemostasis: recommendations for laboratories reporting pediatric samples.
    Ignjatovic V; Kenet G; Monagle P;
    J Thromb Haemost; 2012 Feb; 10(2):298-300. PubMed ID: 22403808
    [No Abstract]   [Full Text] [Related]  

  • 28. AGA Technical Review on Coagulation in Cirrhosis.
    Intagliata NM; Davitkov P; Allen AM; Falck-Ytter YT; Stine JG
    Gastroenterology; 2021 Nov; 161(5):1630-1656. PubMed ID: 34579937
    [No Abstract]   [Full Text] [Related]  

  • 29. New anti-coagulant therapies set to revitalise clinical haemotology practice.
    Aalbers J; Wagenaar P; Klug E
    Cardiovasc J Afr; 2010; 21(6):323-6, 337. PubMed ID: 21135980
    [No Abstract]   [Full Text] [Related]  

  • 30. Expanded coverage for warfarin patients in the USA monitoring clotting time at home.
    Cardiovasc J Afr; 2011; 22(5):280. PubMed ID: 21983956
    [No Abstract]   [Full Text] [Related]  

  • 31. Patient Safety and Quality Improvement: Reducing Risk of Harm.
    Leonard MS
    Pediatr Rev; 2015 Oct; 36(10):448-56; quiz 457-8. PubMed ID: 26430205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assays for measuring rivaroxaban: their suitability and limitations.
    Lindhoff-Last E; Samama MM; Ortel TL; Weitz JI; Spiro TE
    Ther Drug Monit; 2010 Dec; 32(6):673-9. PubMed ID: 20844464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    O'Shea RS; Davitkov P; Ko CW; Rajasekhar A; Su GL; Sultan S; Allen AM; Falck-Ytter Y
    Gastroenterology; 2021 Nov; 161(5):1615-1627.e1. PubMed ID: 34579936
    [No Abstract]   [Full Text] [Related]  

  • 34. Limited English proficient patients and time spent in therapeutic range in a warfarin anticoagulation clinic.
    Rodriguez F; Hong C; Chang Y; Oertel LB; Singer DE; Green AR; López L
    J Am Heart Assoc; 2013 Jul; 2(4):e000170. PubMed ID: 23832325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New oral antithrombotics: a need for laboratory monitoring. For.
    Mismetti P; Laporte S
    J Thromb Haemost; 2010 Apr; 8(4):621-6. PubMed ID: 20102486
    [No Abstract]   [Full Text] [Related]  

  • 36. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
    Ganter MT; Hofer CK
    Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral anticoagulation thresholds.
    Brummel KE; Paradis SG; Branda RF; Mann KG
    Circulation; 2001 Nov; 104(19):2311-7. PubMed ID: 11696471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New oral antithrombotics: a need for laboratory monitoring. Against.
    Bounameaux H; Reber G
    J Thromb Haemost; 2010 Apr; 8(4):627-30. PubMed ID: 20088926
    [No Abstract]   [Full Text] [Related]  

  • 39. Generational performance of three point-of-care testing devices compared with standard laboratory measurement of the international normalised ratio across extended ranges.
    Tay HM; Lai YF; Kong MC; See E; Yeang SH; Koh SK; Shim YT; Chan FSL; Wong WH; Liew CXY; Kaur H; Tan CW; Ho LP; Ng WY; Yeo CP; Ng HJ
    J Clin Pathol; 2019 Apr; 72(4):311-315. PubMed ID: 30674539
    [No Abstract]   [Full Text] [Related]  

  • 40. Inter-assay and instrument variability of anti-Xa--results.
    Kovacs MJ; Keeney M
    Thromb Haemost; 2000 Jul; 84(1):138. PubMed ID: 10928485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.